// App-Quantinova.ai

e12009 : GGNBP2 to suppress tumor growth through modulating ER action in breast cancer.

Researchers

Presenter

  • Yunhui Hu

Principal Investigators

  • Zi-Jian Lan

  • Sheng Zhang

  • Xian Li

  • Huaxin Zhou

  • Jixian Ding

  • Carolyn M. Klinge

  • Austin J. Cooney

  • Zhenmin Lei

  • Jin Zhang

Medical Centers

  • China Tianjin Cancer Prevention Treatment and Research Center, Tianjin Medical University Cancer Hospital, National Clinical Research Center of Cancer, Tianjin, China

  • Division of Life Sciences, Center for Nutrigenomics & Applied Animal Nutrition, Alltech Inc., Nicholasville, KY

  • Department of OB/GYN & Women's Health, University of Louisville Health Sciences Center, Louisville, KY

  • Birth Defects Center, Department of Molecular, Cellular and Craniofacial Biology, University of Louisville Health Sciences Center,, Louisville, KY

  • Department of Biochemistry & Molecular Genetics, University of Louisville Health Sciences Center, Louisville, KY

  • Department of Pediatrics, the University of Texas at Austin Dell Medical School, Austin, TX

  • Department of OB/GYN & Women's Health, University of Louisville Health Sciences Center, Louisville, KY

  • Breast Cancer Center, Tianjin, China

Locations

  • United States

  • China

Companies

  • Alltech Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cyclin D1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved